Pages that link to "Q44584785"

The following pages link to Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma (Q44584785):

Displaying 37 items.

• Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors (Q24314660) (← links)
• A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes (Q24315666) (← links)
• A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1 (Q24323156) (← links)
• Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines (Q24605501) (← links)
• Structure and expression of c-fgr protooncogene mRNA in Epstein-Barr virus converted cell lines (Q24645714) (← links)
• Epstein-Barr virus and Burkitt lymphoma (Q24669890) (← links)
• Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells (Q33929593) (← links)
• Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice (Q34225642) (← links)
• Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. (Q34625121) (← links)
• Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors (Q34767204) (← links)
• Manipulation of immune responses by Epstein-Barr virus. (Q34895103) (← links)
• The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease (Q35550073) (← links)
• High expression of the CD30 molecule in human decidual cells (Q35833942) (← links)
• Burkitt-like lymphoma in an English child: characterisation of tumour biopsy cells and of the derived tumour cell line (Q36027771) (← links)
• Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin (Q36830748) (← links)
• Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity (Q36881880) (← links)
• Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines (Q36920279) (← links)
• Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. (Q36961875) (← links)
• Mechanisms involved in Burkitt's tumor formation (Q37167942) (← links)
• Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity (Q37392755) (← links)
• Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis. (Q37713998) (← links)
• Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A (Q39304933) (← links)
• The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line (Q39592173) (← links)
• Epstein-Barr virus regulates STAT1 through latent membrane protein 1. (Q39736747) (← links)
• Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines. (Q40039134) (← links)
• Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52. (Q40628193) (← links)
• Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells (Q40750094) (← links)
• Direct identification by PCR of EBV types and variants in clinical samples (Q41119648) (← links)
• Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers (Q41447311) (← links)
• BCL-2 induction is part of the strategy of Epstein-Barr virus (Q41490458) (← links)
• Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes (Q41940816) (← links)
• Direct detection of Epstein-Barr virus DNA from a single Reed-Sternberg cell of Hodgkin's disease by polymerase chain reaction (Q43661973) (← links)
• The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells. (Q43991331) (← links)
• Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression (Q45785307) (← links)
• Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis. (Q52904710) (← links)
• Expression of differentiation and adhesion molecules in sporadic Burkitt's lymphoma (Q68553850) (← links)
• Surface marker characterization of EBV-carrying cells in blood of healthy seropositive individuals (Q69838600) (← links)